Bimotrim Injection 200 mg Solution is a Health Canada–registered veterinary drug (DIN 01905031) held by Cross Vetpharm Group Ltd, containing Sulfadoxine. Health Canada lists its status as Cancelled Post Market (status date 27 Jul 2018). Nexara Health has matched 1 registration of Sulfadoxine across 1 other regulated market.
Health Canada registration
| DIN | 01905031 |
|---|---|
| Brand name | Bimotrim Injection |
| Active ingredient | Sulfadoxine |
| Strength | 200 mg |
| Dosage form | Solution |
| Route | Intramuscular ; Intravenous |
| Company | Cross Vetpharm Group Ltd |
| Status | Cancelled Post Market — 27 Jul 2018 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Sulfadoxine registered in other markets
1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Sulfadoxine | Anuh Pharma Limited | Powder | FDA NDC |
See every manufacturer of Sulfadoxine worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Bimotrim Injection (DIN 01905031) marketed in Canada?
No. Health Canada lists DIN 01905031 as Cancelled Post Market as of 27 Jul 2018.
Who holds the Canadian licence for this product?
Cross Vetpharm Group Ltd is the company of record in the Health Canada Drug Product Database.
Is Sulfadoxine registered outside Canada?
Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 01905031, status date 2018-07-27; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 01905031, status date 2018-07-27; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 01905031, status date 2018-07-27; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.